Opportunity, I notice you did not cite the below statements that were included in the BioCurex press release you quoted.
"The development of the point of care test using RECAF technology will take time given the need to perfect the technique and instrument design. There is no assurance the Company will be successful in developing this test, or that the market for this test is anywhere near the size estimated."
News 
Market Data 
Discover 
AI
